trending Market Intelligence /marketintelligence/en/news-insights/trending/5E0Iz2i2mrQxH9ROe8XNnA2 content esgSubNav
In This List

Impax Laboratories names CEO

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Impax Laboratories names CEO

Impax Laboratories Inc. appointed Paul Bisaro as the company's president and CEO, replacing J. Kevin Buchi, who had been serving in the positions on an interim basis.

Bisaro, the former executive chairman of Allergan PLC, will also join the Impax board. Bisaro continues to serve on the Allergan board.